Combination treatment for multiple sclerosis

Details for Australian Patent Application No. 2005318183 (hide)

Owner Merck Serono SA

Inventors De Luca, Giampiero

Agent Griffith Hack

Pub. Number AU-B-2005318183

PCT Pub. Number WO2006/067134

Priority 04106910.5 22.12.04 EP; 60/638,674 22.12.04 US

Filing date 20 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 31 March 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 31/7076 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/067134 Priority application(s): WO2006/067134

30 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

31 March 2011 Application Accepted

  Published as AU-B-2005318183

28 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005318185-A method for the preparation of a starter culture

2005318173-CC-chemokine antagonists